Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2024

Open Access 04-01-2024 | Portal Hypertension | Original Article

Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature

Authors: Gal Sadlik, Redmond-Craig Anderson, Xiaomeng Lei, Steven Yong Cen, Vinay A. Duddalwar, Tse-Ling Fong

Published in: Digestive Diseases and Sciences | Issue 3/2024

Login to get access

Abstract

Background and aims

Pseudocirrhosis is a poorly understood acquired morphologic change of the liver that occurs in the setting of metastatic malignancy and radiographically resembles cirrhosis. Pseudocirrhosis has been primarily described in metastatic breast carcinoma, with few case reports arising from other primary malignancies. We present 29 cases of pseudocirrhosis, including several cases from primary malignancies not previously described.

Methods

Radiologic, clinical, demographic, and biomedical data were collected retrospectively and analyzed. We compared clinical and radiologic characteristics and outcomes between patients with pseudocirrhosis arising in metastatic breast cancer and non-breast primary malignancies.

Results

Among the 29 patients, 14 had breast cancer and 15 had non-breast primaries including previously never reported primaries associated with pseudocirrhosis, melanoma, renal cell carcinoma, appendiceal carcinoid, and cholangiocarcinoma. Median time from cancer diagnosis to development of pseudocirrhosis was 80.8 months for patients with primary breast cancer and 29.8 months for non-breast primary (p = 0.02). Among all patients, 15 (52%) had radiographic features of portal hypertension. Radiographic evidence of portal hypertension was identified in 28.6% of breast cancer patients, compared to 73.3% of those with non-breast malignancies (p = 0.03).

Conclusion

Pseudocirrhosis has most commonly been described in the setting of metastatic breast cancer but occurs in any metastatic disease to the liver. Our study suggests that portal hypertensive complications are more common in the setting of non-breast primary cancers than in metastatic breast cancer. Prior exposure to multiple chemotherapeutic agents, and agents known to cause sinusoidal injury, is a common feature but not essential for the development of pseudocirrhosis.
Literature
2.
go back to reference Jeong WK, Choi SY, Kim J. Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer. Clin Mol Hepatol. 2013;19:190–194.PubMedPubMedCentralCrossRef Jeong WK, Choi SY, Kim J. Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer. Clin Mol Hepatol. 2013;19:190–194.PubMedPubMedCentralCrossRef
3.
4.
go back to reference Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging. 2007;31:6–10.PubMedCrossRef Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging. 2007;31:6–10.PubMedCrossRef
5.
go back to reference Busni NA. Hepar lobatum carcinomatosum. Virchows Arch Path Anat. 1924;252:727–733.CrossRef Busni NA. Hepar lobatum carcinomatosum. Virchows Arch Path Anat. 1924;252:727–733.CrossRef
6.
go back to reference Villani R, Di Cosimo F, Sangineto M, Romano AD, Serviddio G. Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis. Sci Rep. 2022;12:19865.PubMedPubMedCentralCrossRef Villani R, Di Cosimo F, Sangineto M, Romano AD, Serviddio G. Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis. Sci Rep. 2022;12:19865.PubMedPubMedCentralCrossRef
7.
go back to reference Honma K. Hepar lobatum carcinomatosum due to metastatic breast carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987;410:465–469.PubMedCrossRef Honma K. Hepar lobatum carcinomatosum due to metastatic breast carcinoma. Virchows Arch A Pathol Anat Histopathol. 1987;410:465–469.PubMedCrossRef
8.
go back to reference Qizilbash A, Kontozoglou T, Sianos J, Scully K. Hepar lobatum associated with chemotherapy and metastatic breast cancer. Arch Pathol Lab Med. 1987;111:58–61.PubMed Qizilbash A, Kontozoglou T, Sianos J, Scully K. Hepar lobatum associated with chemotherapy and metastatic breast cancer. Arch Pathol Lab Med. 1987;111:58–61.PubMed
9.
go back to reference Chin NW, Chapman I, Jimenez FA. Complete chemotherapeutic regression of hepatic metastases with resultant hepar lobatum. Am J Gastroenterol. 1987;82:149–151.PubMed Chin NW, Chapman I, Jimenez FA. Complete chemotherapeutic regression of hepatic metastases with resultant hepar lobatum. Am J Gastroenterol. 1987;82:149–151.PubMed
10.
go back to reference Watson AJ. Diffuse intra-sinusoidal metastatic carcinoma of the liver. J Pathol Bacteriol. 1955;69:207–217.PubMedCrossRef Watson AJ. Diffuse intra-sinusoidal metastatic carcinoma of the liver. J Pathol Bacteriol. 1955;69:207–217.PubMedCrossRef
11.
go back to reference Micolonghi T, Pineda E, Stanley MM. Metastatic carcinomatous cirrhosis of the liver; report of a case in which death followed hemorrhage from esophageal varices and hepatic coma. AMA Arch Pathol. 1958;65:56–62.PubMed Micolonghi T, Pineda E, Stanley MM. Metastatic carcinomatous cirrhosis of the liver; report of a case in which death followed hemorrhage from esophageal varices and hepatic coma. AMA Arch Pathol. 1958;65:56–62.PubMed
12.
go back to reference Borja ER, Hori JM, Pugh RP. Metastatic carcinomatosis of the liver mimicking cirrhosis: case report and review of the literature. Cancer. 1975;35:445–449.PubMedCrossRef Borja ER, Hori JM, Pugh RP. Metastatic carcinomatosis of the liver mimicking cirrhosis: case report and review of the literature. Cancer. 1975;35:445–449.PubMedCrossRef
13.
go back to reference Knouse P, Hancock C, Iwaz S, Kaiser P. Metastatic carcinomatosis cirrhosis: a rare pattern of metastasis. Cureus. 2019;11:e3876.PubMedPubMedCentral Knouse P, Hancock C, Iwaz S, Kaiser P. Metastatic carcinomatosis cirrhosis: a rare pattern of metastasis. Cureus. 2019;11:e3876.PubMedPubMedCentral
15.
go back to reference Strong GF. Pick’s disease (Mediastino-pericarditic Pseudo-cirrhosis of the Liver): a case, with pericardial resection and recovery. Can Med Assoc J. 1938;39:247–249.PubMedPubMedCentral Strong GF. Pick’s disease (Mediastino-pericarditic Pseudo-cirrhosis of the Liver): a case, with pericardial resection and recovery. Can Med Assoc J. 1938;39:247–249.PubMedPubMedCentral
16.
go back to reference Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. Am J Roentgenol. 1994;163:1385–1388.CrossRef Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME. CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. Am J Roentgenol. 1994;163:1385–1388.CrossRef
17.
go back to reference Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V. Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol. 2013;12:834–836.PubMedCrossRef Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V. Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol. 2013;12:834–836.PubMedCrossRef
18.
go back to reference Harbin WP, Robert NJ, Ferrucci JT. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273–283.PubMedCrossRef Harbin WP, Robert NJ, Ferrucci JT. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology. 1980;135:273–283.PubMedCrossRef
19.
go back to reference Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47–50.PubMedCrossRef Torres WE, Whitmire LF, Gedgaudas-McClees K, Bernardino ME. Computed tomography of hepatic morphologic changes in cirrhosis of the liver. J Comput Assist Tomogr. 1986;10:47–50.PubMedCrossRef
20.
go back to reference Kudo M, Zheng RQ, Kim SR et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology. 2008;51 Suppl 1:17–26.PubMedCrossRef Kudo M, Zheng RQ, Kim SR et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology. 2008;51 Suppl 1:17–26.PubMedCrossRef
22.
go back to reference Cerný E, Bucek J. Tumor-related partial pseudocirrhosis of the liver. Cesk Patol. 1992;28:53–56.PubMed Cerný E, Bucek J. Tumor-related partial pseudocirrhosis of the liver. Cesk Patol. 1992;28:53–56.PubMed
23.
go back to reference Shirkhoda A, Baird S. Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging. 1994;19:39–42.PubMedCrossRef Shirkhoda A, Baird S. Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings. Abdom Imaging. 1994;19:39–42.PubMedCrossRef
24.
go back to reference Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. Am J Roentgenol. 1987;148:717–722.CrossRef Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG. Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. Am J Roentgenol. 1987;148:717–722.CrossRef
25.
26.
go back to reference Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity. ESMO Open. 2020;5:e000695.PubMedPubMedCentralCrossRef Engelman D, Moreau M, Lepida A, Zaouak Y, Paesmans M, Awada A. Metastatic breast cancer and pseudocirrhosis: an unknown clinical entity. ESMO Open. 2020;5:e000695.PubMedPubMedCentralCrossRef
27.
go back to reference Gopalakrishnan D, Shajihan A, Purysko AS, Abraham J. Pseudocirrhosis in breast cancer—experience from an academic cancer center. Front Oncol. 2021;11:679163.PubMedPubMedCentralCrossRef Gopalakrishnan D, Shajihan A, Purysko AS, Abraham J. Pseudocirrhosis in breast cancer—experience from an academic cancer center. Front Oncol. 2021;11:679163.PubMedPubMedCentralCrossRef
28.
go back to reference Hyun BH, Singer EP, Sharrett RH. Esophageal varices and metastatic carcinoma of liver. A report of three cases and review of the literature. Arch Pathol. 1964;77:292–298.PubMed Hyun BH, Singer EP, Sharrett RH. Esophageal varices and metastatic carcinoma of liver. A report of three cases and review of the literature. Arch Pathol. 1964;77:292–298.PubMed
29.
go back to reference Shreve LA, O’Leary C, Clark TWI, Stavropoulos SW, Soulen MC. Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis. J Gastrointest Oncol. 2022;13:279–287.PubMedPubMedCentralCrossRef Shreve LA, O’Leary C, Clark TWI, Stavropoulos SW, Soulen MC. Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis. J Gastrointest Oncol. 2022;13:279–287.PubMedPubMedCentralCrossRef
30.
go back to reference Geeroms B, De Hertogh G, Vanslembrouck R, Wildiers H, Nevens F, Maleux G. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension-induced refractory ascites due to metastatic carcinomatous liver disease. J Vasc Interv Radiol. 2018;29:1713–1716.PubMedCrossRef Geeroms B, De Hertogh G, Vanslembrouck R, Wildiers H, Nevens F, Maleux G. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension-induced refractory ascites due to metastatic carcinomatous liver disease. J Vasc Interv Radiol. 2018;29:1713–1716.PubMedCrossRef
31.
go back to reference Kashyap R, Reddy R, Voona MK. Pseudocirrhosis of the liver in setting of metastatic carcinoma breast: an ominous sign to be remembered. Indian J Nucl Med. 2018;33:86–87.PubMedPubMedCentral Kashyap R, Reddy R, Voona MK. Pseudocirrhosis of the liver in setting of metastatic carcinoma breast: an ominous sign to be remembered. Indian J Nucl Med. 2018;33:86–87.PubMedPubMedCentral
32.
go back to reference Ma WL, Chang DY, Lin CH et al. Clinical outcomes of metastatic breast cancer in patients having imaging liver pseudocirrhosis with or without evident varices. Oncologist. 2022;27:1008–1015.PubMedPubMedCentralCrossRef Ma WL, Chang DY, Lin CH et al. Clinical outcomes of metastatic breast cancer in patients having imaging liver pseudocirrhosis with or without evident varices. Oncologist. 2022;27:1008–1015.PubMedPubMedCentralCrossRef
33.
go back to reference Huppert LA, Walker Z, Li M et al. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Res Treat. 2023;197:137–148.PubMedCrossRef Huppert LA, Walker Z, Li M et al. Clinical characteristics and outcomes in patients with metastatic breast cancer and pseudocirrhosis: a single center retrospective cohort study. Breast Cancer Res Treat. 2023;197:137–148.PubMedCrossRef
34.
go back to reference Horn SR, Stoltzfus KC, Lehrer EJ et al. Epidemiology of liver metastases. Cancer Epidemiol. 2020;67:101760.PubMedCrossRef Horn SR, Stoltzfus KC, Lehrer EJ et al. Epidemiology of liver metastases. Cancer Epidemiol. 2020;67:101760.PubMedCrossRef
35.
go back to reference Rashid NS, Grible JM, Clevenger CV, Harrell JC. Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis. 2021;38:263–277.PubMedPubMedCentralCrossRef Rashid NS, Grible JM, Clevenger CV, Harrell JC. Breast cancer liver metastasis: current and future treatment approaches. Clin Exp Metastasis. 2021;38:263–277.PubMedPubMedCentralCrossRef
36.
go back to reference Cummings MC, Simpson PT, Reid LE et al. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014;232:23–31.PubMedCrossRef Cummings MC, Simpson PT, Reid LE et al. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014;232:23–31.PubMedCrossRef
37.
go back to reference Vuppalanchi R, Saxena R, Storniolo AMV, Chalasani N. Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib. Hepatology. 2017;65:1762–1764.PubMedCrossRef Vuppalanchi R, Saxena R, Storniolo AMV, Chalasani N. Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib. Hepatology. 2017;65:1762–1764.PubMedCrossRef
38.
go back to reference Aoyagi T, Takabe K, Tamanuki T, Matsubara H, Matsuzaki H. Pseudocirrhosis after chemotherapy in breast cancer, case reports. Breast Cancer. 2018;25:614–618.PubMedCrossRef Aoyagi T, Takabe K, Tamanuki T, Matsubara H, Matsuzaki H. Pseudocirrhosis after chemotherapy in breast cancer, case reports. Breast Cancer. 2018;25:614–618.PubMedCrossRef
39.
go back to reference Zeina AR, Abu-Mouch S, Mari A. Pseudocirrhosis in metastatic breast cancer. Isr Med Assoc J. 2017;19:328.PubMed Zeina AR, Abu-Mouch S, Mari A. Pseudocirrhosis in metastatic breast cancer. Isr Med Assoc J. 2017;19:328.PubMed
40.
go back to reference Liu CH, Chao TY. Education and imaging. Hepatobiliary and pancreatic: pseudocirrhosis after chemotherapy. J Gastroenterol Hepatol. 2011;26:788.PubMedCrossRef Liu CH, Chao TY. Education and imaging. Hepatobiliary and pancreatic: pseudocirrhosis after chemotherapy. J Gastroenterol Hepatol. 2011;26:788.PubMedCrossRef
41.
go back to reference Chandrakar V, Isaacs C. Breast cancer-related pseudocirrhosis and esophageal varices. Breast J. 2005;11:301–302.PubMedCrossRef Chandrakar V, Isaacs C. Breast cancer-related pseudocirrhosis and esophageal varices. Breast J. 2005;11:301–302.PubMedCrossRef
42.
go back to reference Fournier C, Tisman G, Kleinman R, Park Y, Macdonald WD. Clinical evidence for overcoming capecitabine resistance in a woman with breast cancer terminating in radiologically occult micronodular pseudo-cirrhosis with portal hypertension: a case report. J Med Case Rep. 2010;4:112.PubMedPubMedCentralCrossRef Fournier C, Tisman G, Kleinman R, Park Y, Macdonald WD. Clinical evidence for overcoming capecitabine resistance in a woman with breast cancer terminating in radiologically occult micronodular pseudo-cirrhosis with portal hypertension: a case report. J Med Case Rep. 2010;4:112.PubMedPubMedCentralCrossRef
43.
go back to reference Kang SP, Taddei T, McLennan B, Lacy J. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. World J Gastroenterol. 2008;14:1622–1624.PubMedPubMedCentralCrossRef Kang SP, Taddei T, McLennan B, Lacy J. Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. World J Gastroenterol. 2008;14:1622–1624.PubMedPubMedCentralCrossRef
44.
go back to reference Battisti S, Guida FM, Pagliara E, Tonini G, Zobel BB, Santini D. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clin Colorectal Cancer. 2014;13:e13-15.PubMedCrossRef Battisti S, Guida FM, Pagliara E, Tonini G, Zobel BB, Santini D. Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view. Clin Colorectal Cancer. 2014;13:e13-15.PubMedCrossRef
45.
go back to reference Kumamoto K, Endo S, Isohata N et al. Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases. Mol Clin Oncol. 2017;6:63–66.PubMedCrossRef Kumamoto K, Endo S, Isohata N et al. Pseudocirrhosis caused by regorafenib in an advanced rectal cancer patient with multiple liver metastases. Mol Clin Oncol. 2017;6:63–66.PubMedCrossRef
46.
go back to reference Mitani S, Kadowaki S, Taniguchi H, Muto H, Muro K. Pseudocirrhosis in gastric cancer with diffuse liver metastases after a dramatic response to chemotherapy. Case Rep Oncol. 2016;9:106–111.PubMedPubMedCentralCrossRef Mitani S, Kadowaki S, Taniguchi H, Muto H, Muro K. Pseudocirrhosis in gastric cancer with diffuse liver metastases after a dramatic response to chemotherapy. Case Rep Oncol. 2016;9:106–111.PubMedPubMedCentralCrossRef
48.
go back to reference Shinoda T, Tanahashi T, Sakuratani T et al. Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: a case report. Mol Clin Oncol. 2022;16:11.PubMedCrossRef Shinoda T, Tanahashi T, Sakuratani T et al. Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: a case report. Mol Clin Oncol. 2022;16:11.PubMedCrossRef
49.
go back to reference Kobashigawa C, Nakamoto M, Hokama A, Hirata T, Kinjo F, Fujita J. Pseudocirrhosis in metastatic esophageal cancer. South Med J. 2010;103:488–489.PubMedCrossRef Kobashigawa C, Nakamoto M, Hokama A, Hirata T, Kinjo F, Fujita J. Pseudocirrhosis in metastatic esophageal cancer. South Med J. 2010;103:488–489.PubMedCrossRef
51.
go back to reference Nakano S, Suzuki T, Takase Y et al. Pseudocirrhosis caused by lung adenocarcinoma with diffuse liver metastasis: an autopsy case report. Thorac Cancer. 2021;12:2046–2049.PubMedPubMedCentralCrossRef Nakano S, Suzuki T, Takase Y et al. Pseudocirrhosis caused by lung adenocarcinoma with diffuse liver metastasis: an autopsy case report. Thorac Cancer. 2021;12:2046–2049.PubMedPubMedCentralCrossRef
52.
go back to reference Zanazanian A, Kalani A, Tabibian JH. Pseudocirrhosis in a patient with new-onset dysphagia and history of ovarian carcinoma. ACG Case Rep J. 2018;5:e29.PubMedPubMedCentralCrossRef Zanazanian A, Kalani A, Tabibian JH. Pseudocirrhosis in a patient with new-onset dysphagia and history of ovarian carcinoma. ACG Case Rep J. 2018;5:e29.PubMedPubMedCentralCrossRef
53.
go back to reference Harry BL, Smith ML, Burton JR, Dasari A, Eckhardt SG, Diamond JR. Medullary thyroid cancer and pseudocirrhosis: case report and literature review. Curr Oncol. 2012;19:e36-41.PubMedPubMedCentralCrossRef Harry BL, Smith ML, Burton JR, Dasari A, Eckhardt SG, Diamond JR. Medullary thyroid cancer and pseudocirrhosis: case report and literature review. Curr Oncol. 2012;19:e36-41.PubMedPubMedCentralCrossRef
54.
go back to reference Adler M, Tang I, Gach MW, MacFaul G. Recurrent metastatic breast cancer presenting with portal hypertension and pseudocirrhosis. BMJ Case Rep. 2019;12:e231044.PubMedPubMedCentralCrossRef Adler M, Tang I, Gach MW, MacFaul G. Recurrent metastatic breast cancer presenting with portal hypertension and pseudocirrhosis. BMJ Case Rep. 2019;12:e231044.PubMedPubMedCentralCrossRef
55.
go back to reference Sonnenblick A, Appelbaum L, Peretz T. Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatment. Onkologie. 2011;34:199–201.PubMedCrossRef Sonnenblick A, Appelbaum L, Peretz T. Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatment. Onkologie. 2011;34:199–201.PubMedCrossRef
56.
go back to reference Nascimento AB, Mitchell DG, Rubin R, Weaver E. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology. 2001;221:117–121.PubMedCrossRef Nascimento AB, Mitchell DG, Rubin R, Weaver E. Diffuse desmoplastic breast carcinoma metastases to the liver simulating cirrhosis at MR imaging: report of two cases. Radiology. 2001;221:117–121.PubMedCrossRef
57.
go back to reference Viguier J, De Muret A, Bacq Y. Ascites due to portal hypertension from breast cancer-related metastatic liver infiltration. Gastroenterol Clin Biol. 2006;30:903–905.PubMedCrossRef Viguier J, De Muret A, Bacq Y. Ascites due to portal hypertension from breast cancer-related metastatic liver infiltration. Gastroenterol Clin Biol. 2006;30:903–905.PubMedCrossRef
59.
60.
go back to reference Hidalgo-Blanco A, Aguirresarobe-Gil de San Vicente M, Aresti S, de Miguel E, Cabriada-Nuno JL. Pseudocirrhosis in metastatic breast cancer. Gastroenterol Hepatol. 2018;41:111–113.PubMedCrossRef Hidalgo-Blanco A, Aguirresarobe-Gil de San Vicente M, Aresti S, de Miguel E, Cabriada-Nuno JL. Pseudocirrhosis in metastatic breast cancer. Gastroenterol Hepatol. 2018;41:111–113.PubMedCrossRef
61.
go back to reference Takata K, Mogi A, Yamauchi R, Shakado S, Hirai F. Pseudocirrhosis due to desmoplastic response to chemotherapy in breast cancer liver metastases. Cureus. 2022;14:e25321.PubMedPubMedCentral Takata K, Mogi A, Yamauchi R, Shakado S, Hirai F. Pseudocirrhosis due to desmoplastic response to chemotherapy in breast cancer liver metastases. Cureus. 2022;14:e25321.PubMedPubMedCentral
62.
go back to reference Schreiner SA, Gorman B, Stephens DH. Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis. Mayo Clin Proc. 1998;73:780–783.PubMedCrossRef Schreiner SA, Gorman B, Stephens DH. Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis. Mayo Clin Proc. 1998;73:780–783.PubMedCrossRef
63.
go back to reference Calistri L, Rastrelli V, Nardi C et al. Imaging of the chemotherapy-induced hepatic damage: yellow liver, blue liver, and pseudocirrhosis. World J Gastroenterol. 2021;27:7866–7893.PubMedPubMedCentralCrossRef Calistri L, Rastrelli V, Nardi C et al. Imaging of the chemotherapy-induced hepatic damage: yellow liver, blue liver, and pseudocirrhosis. World J Gastroenterol. 2021;27:7866–7893.PubMedPubMedCentralCrossRef
64.
go back to reference DeLeve LD, Valla DC, Garcia-Tsao G. American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.PubMedCrossRef DeLeve LD, Valla DC, Garcia-Tsao G. American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.PubMedCrossRef
65.
go back to reference Alberti N, Bechade D, Dupuis F et al. Hepar lobatum carcinomatosum associated with liver metastases from breast cancer: report of five cases. Diagn Interv Imaging. 2015;96:73–78.PubMedCrossRef Alberti N, Bechade D, Dupuis F et al. Hepar lobatum carcinomatosum associated with liver metastases from breast cancer: report of five cases. Diagn Interv Imaging. 2015;96:73–78.PubMedCrossRef
Metadata
Title
Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature
Authors
Gal Sadlik
Redmond-Craig Anderson
Xiaomeng Lei
Steven Yong Cen
Vinay A. Duddalwar
Tse-Ling Fong
Publication date
04-01-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08226-3

Other articles of this Issue 3/2024

Digestive Diseases and Sciences 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine